KX2-391

• Description :

  KX2-391, the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines.

• CAS Number :

  897016-82-9

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  431.53

• Molecular Formula :

  C26H29N3O3

• Notes :

  Research use only, not for human use.

• Receptor :

  Src (Hep 3B) | Src (Hep G2) | Src (HuH7) | Src (PLC/PRF/5)